| ISIN | LU1878180014 |
|---|---|
| Valorennummer | 43579879 |
| Bloomberg Global ID | |
| Fondsname | MEMNON FUND-Memnon European Fund I2 - EUR |
| Fondsanbieter |
Zadig Gestion Luxembourg
Telefon: +352 26 47 6301 Web: www.zadig.lu |
| Fondsanbieter | Zadig Gestion Luxembourg |
| Vertreter in der Schweiz |
Reyl & Cie S.A. Genève Telefon: +41 22 816 80 00 |
| Distributor(en) | CACEIS (Switzerland) SA |
| Anlagekategorie | Aktienfonds |
| EFC-Kategorie | |
| Anteilskategorie | Accumulation |
| Domizilland | Luxemburg |
| Konditionen bei der Ausgabe | keine Ausgabekommission und/oder Gebühren zugunsten des Fonds (Ausgabe erfolgt zum Inventarwert) |
| Konditionen bei der Rücknahme | Keine Rücknahmekommission und/oder Gebühren zugunsten des Fonds (Rücknahme erfolgt zum Inventarwert) |
| Investment-Strategie *** | The objective of this Sub-Fund is to maximise long term capital growth by investing primarily in quoted equity listed on or dealt in Regulated Markets within the EEA, UK and Switzerland which are issued by companies with principal offices in the EEA, UK and Switzerland. To achieve its investment objective, this Sub-Fund will base its investments on fundamental research in the selection of Transferable Securities for long positions. |
| Besonderheiten |
| Aktueller Preis * | 398.22 EUR | 29.12.2025 |
|---|---|---|
| Vorheriger Preis * | 396.86 EUR | 24.12.2025 |
| 52 Wochen Hoch * | 398.46 EUR | 19.12.2025 |
| 52 Wochen Tief * | 379.72 EUR | 21.11.2025 |
| NAV * | 398.22 EUR | 29.12.2025 |
| Ausgabepreis * | 398.22 EUR | 29.12.2025 |
| Rücknahmepreis * | ||
| Schlusskurs * | ||
| Indikativer Minimalpreis | ||
| Fondsvermögen *** | 346'828'397 | |
| Anteilsklassevermögen *** | 189'089'269 | |
| Trading Information SIX | ||
| YTD-Performance | - | - |
|---|---|---|
| YTD-Performance (in CHF) | - | - |
| 1 Monat | +1.63% |
01.12.2025 - 29.12.2025
01.12.2025 29.12.2025 |
| 3 Monate | +4.87% |
21.11.2025 - 29.12.2025
21.11.2025 29.12.2025 |
| 6 Monate | - | - |
| 1 Jahr | - | - |
| 2 Jahre | - | - |
| 3 Jahre | - | - |
| 5 Jahre | - | - |
| Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AstraZeneca PLC | 6.53% | |
|---|---|---|
| Societe Generale SA | 6.03% | |
| ASML Holding NV | 5.59% | |
| Merck KGaA | 5.31% | |
| STMicroelectronics NV | 5.30% | |
| Erste Group Bank AG. | 5.03% | |
| Compagnie de Saint-Gobain SA | 4.84% | |
| Publicis Groupe SA | 4.45% | |
| Kerry Group PLC Class A | 4.44% | |
| Informa PLC | 4.30% | |
| Letzte Daten-Aktualisierung | 30.09.2025 | |
| TER *** | 1.069% |
|---|---|
| Datum TER *** | 31.08.2025 |
| Performance Fee *** | 15.00% |
| PTR | |
| Max. Management Fee *** | 1.25% |
| Ongoing Charges *** | 1.10% |
|
SRRI ***
|
|
| Datum SRRI *** | 30.11.2025 |